Search research articles
Contact Us
Filters
Showing results (381-390 of 743) with videos related to
Page
of 75
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
May 7, 2008
Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B
Klaus Strobel, Reinhard Dummer, Hans C Steinert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2008
HER3 is a determinant for poor prognosis in melanoma
Markus Reschke, Daniela Mihic-Probst, Edward Htun van der Horst, et al.
Swiss Medical Weekly
|
February 23, 2016
The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma
Reinhard Dummer, Marco Siano, Robert E Hunger, et al.
Journal of the American Academy of Dermatology
|
May 20, 2014
Primary cutaneous follicle center lymphoma with diffuse CD30 expression: a report of 4 cases of a rare variant
Werner Kempf, Dmitry V Kazakov, Arno Rütten, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2013
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients
Simone M Goldinger, Lisa Zimmer, Carsten Schulz, et al.
Acta Dermato-Venereologica
|
April 26, 2018
Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study
Marie-Charlotte Brüggen, Katrin Kerl, Eugenia Haralambieva, et al.
Cancer Treatment Reviews
|
April 19, 2021
Neurological complications of cancer immunotherapy
Patrick Roth, Sebastian Winklhofer, Antonia M S Müller, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 11, 2010
Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients
Natko Nuber, Alessandra Curioni-Fontecedro, Claudia Matter, et al.
Blood
|
May 27, 2004
Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas
Reinhard Dummer, Jessica C Hassel, Friederike Fellenberg, et al.
Oncology Reports
|
May 23, 2012
Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07
Peter Schraml, Adriana von Teichman, Daniela Mihic-Probst, et al.
Page
of 75
Search research articles
Search
Showing results (381-390 of 743) with videos related to
Sort By:
Page
of 75
European Journal of Nuclear Medicine and Molecular Imaging
|
May 7, 2008
Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B
Klaus Strobel, Reinhard Dummer, Hans C Steinert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 14, 2008
HER3 is a determinant for poor prognosis in melanoma
Markus Reschke, Daniela Mihic-Probst, Edward Htun van der Horst, et al.
Swiss Medical Weekly
|
February 23, 2016
The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma
Reinhard Dummer, Marco Siano, Robert E Hunger, et al.
Journal of the American Academy of Dermatology
|
May 20, 2014
Primary cutaneous follicle center lymphoma with diffuse CD30 expression: a report of 4 cases of a rare variant
Werner Kempf, Dmitry V Kazakov, Arno Rütten, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2013
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients
Simone M Goldinger, Lisa Zimmer, Carsten Schulz, et al.
Acta Dermato-Venereologica
|
April 26, 2018
Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study
Marie-Charlotte Brüggen, Katrin Kerl, Eugenia Haralambieva, et al.
Cancer Treatment Reviews
|
April 19, 2021
Neurological complications of cancer immunotherapy
Patrick Roth, Sebastian Winklhofer, Antonia M S Müller, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 11, 2010
Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients
Natko Nuber, Alessandra Curioni-Fontecedro, Claudia Matter, et al.
Blood
|
May 27, 2004
Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas
Reinhard Dummer, Jessica C Hassel, Friederike Fellenberg, et al.
Oncology Reports
|
May 23, 2012
Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07
Peter Schraml, Adriana von Teichman, Daniela Mihic-Probst, et al.
Page
of 75